Literature DB >> 12453634

The ceruloplasmin and hydrogen peroxide system induces alpha-synuclein aggregation in vitro.

Kyung Sik Kim1, Soo Young Choi, Hyeok Yil Kwon, Moo Ho Won, Tae-Cheon Kang, Jung Hoon Kang.   

Abstract

Alpha-synuclein is a key component of Lewy bodies in the brain of patients with Parkinson's disease (PD) and recent studies suggest that oxidative stress reactions might contribute to abnormal aggregation of this molecule. Since hydrogen peroxide-mediated ceruloplasmin (CP) modification can induce the formation of free radicals and release of copper ions, we investigated the role of CP in the aggregation of alpha-synuclein. When alpha-synuclein was incubated with both CP and H(2)O(2), alpha-synuclein concomitantly was induced to be aggregated. Thioflavin-S staining of alpha-synuclein aggregates showed that they displayed characteristic fibrillar structures. Hydroxyl radical scavengers and spin-trapping agent such as 5,5'-dimethyl 1-pyrolline N-oxide and tert-butyl-alpha-phenylnitrone significantly inhibited the aggregation of alpha-synuclein. Copper chelator, penicillamine also inhibited the CP/H(2)O(2) system-induced alpha-synuclein aggregation. This indicates that the aggregation of alpha-synuclein can be mediated by the CP/H(2)O(2) system via the generation of hydroxyl radical. The CP/H(2)O(2) system-induced alpha-synuclein aggregation resulted in the generation of protein carbonyl derivatives. Antioxidant molecules, carnosine, homocarnosine and anserine significantly inhibited the CP/H(2)O(2) system-induced aggregation of alpha-synuclein. These results suggest that the CP/H(2)O(2) system may be related to abnormal aggregation of alpha-synuclein which may be involved in the pathogenesis of PD and related disorders. Copyright 2002 Société françcaise de biochimie et biologie moléculaire / Editions scientifiques et médicales Elsevier SAS

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12453634     DOI: 10.1016/s0300-9084(02)01435-9

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  8 in total

Review 1.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

Review 2.  Carnosine and Related Peptides: Therapeutic Potential in Age-Related Disorders.

Authors:  José H Cararo; Emilio L Streck; Patricia F Schuck; Gustavo da C Ferreira
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

3.  Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.

Authors:  Annadurai Anandhan; Humberto Rodriguez-Rocha; Iryna Bohovych; Amy M Griggs; Laura Zavala-Flores; Elsa M Reyes-Reyes; Javier Seravalli; Lia A Stanciu; Jaekwon Lee; Jean-Christophe Rochet; Oleh Khalimonchuk; Rodrigo Franco
Journal:  Neurobiol Dis       Date:  2014-12-08       Impact factor: 5.996

4.  Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders?

Authors:  Manfred Windisch; Birgit Hutter-Paier; Edith Schreiner; Robert Wronski
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

5.  Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson's disease.

Authors:  Kersi J Bharucha; Joyce K Friedman; Andrea S Vincent; Elliott D Ross
Journal:  J Neurol       Date:  2009-01-22       Impact factor: 4.849

6.  DIGE proteome analysis reveals suitability of ischemic cardiac in vitro model for studying cellular response to acute ischemia and regeneration.

Authors:  Sina Haas; Heinz-Georg Jahnke; Nora Moerbt; Martin von Bergen; Seyedhossein Aharinejad; Olena Andrukhova; Andrea A Robitzki
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

7.  Oxidative modification of human ceruloplasmin induced by a catechol neurotoxin, salsolinol.

Authors:  Seung-Sub Kim; Jae Yoon Kang; Jung Hoon Kang
Journal:  BMB Rep       Date:  2016-01       Impact factor: 4.778

8.  Altered serum copper homeostasis suggests higher oxidative stress and lower antioxidant capability in patients with chronic hepatitis B.

Authors:  Yansong Huang; Yuan Zhang; Zhexuan Lin; Ming Han; Hongqiu Cheng
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.